Metabolic disorders in general and hypercholesterolemia in particular is a primary health concern affecting the lives of over 1.8 billion across the globe. Left unnoticed or unattended, this leads to cardiovascular disorders (CVD) which affects over 532 million people globally. Accounted for more than 19 million deaths, CVD is responsible for 32% deaths worldwide.